MK-4646

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

HIV InfectionHealthy

Phase 1

MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)

CompletedNCT07042945

Merck Sharp & Dohme LLCHIV Infection

Start: 2025-07-09End: 2026-06-05Updated: 2026-06-22

A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)

CompletedNCT07199452

Merck Sharp & Dohme LLCHealthy

Start: 2025-10-28End: 2026-01-07Updated: 2026-01-29

A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007)

Not yet recruitingNCT07785830

Merck Sharp & Dohme LLCHealthy

Start: 2026-09-25End: 2026-11-10Target: 16Updated: 2026-08-25